Latest Advances

  • Journal: Dermatology online journal
  • Published —
Bullous eosinophilic annular erythema.
  • Journal: Cutaneous and ocular toxicology
  • Published —
Cutaneous manifestations related to the COVID-19 pandemic: a review article.
  • Condition: Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis
  • Journal: Lancet (London, England)
  • Treatment Used: Upadacitinib Plus Topical Corticosteroids
  • Number of Patients: 901
  • Published —
This study assessed the safety and effectiveness of upadacitinib plus topical corticosteroids for the treatment of adolescents and adults with moderate-to-severe atopic dermatitis.
  • Condition: Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis
  • Journal: Lancet (London, England)
  • Treatment Used: Once-Daily Upadacitinib
  • Number of Patients: 847
  • Published —
The purpose of the study was to assess the effectiveness and safety of upadacitinib compared with placebo for the treatment of moderate to severe atopic dermatitis.
  • Condition: Severe Atopic Dermatitis
  • Journal: Einstein (Sao Paulo, Brazil)
  • Treatment Used: Dupilumab
  • Number of Patients: 2
  • Published —
This study reports two cases of adolescent siblings with severe atopic dermatitis treated with dupilumab.
  • Condition: Children with Atopic Dermatitis (AD) and Cow's Milk Protein (CMP) Allergy
  • Journal: Nutrients
  • Treatment Used: Probiotic Lactobacillus Rhamnosus and Lactobacillus Casei
  • Number of Patients: 0
  • Published —
This study evaluated the effectiveness of probiotic Lactobacillus rhamnosus and Lactobacillus casei in children with atopic dermatitis (AD) and a cow's milk protein (CMP) allergy.
Showing 1-12 of 203